VioBio Lab and collaborators found 2EyesVision.
Members of VioBio Lab and collaborators have founded a new spin-off company, 2Eyes Vision, to commercialize the SimVis technology developed in the group, protected by several patents. A working prototype simulating multifocal corrections has been demonstrated with great success to key opinion leaders in several clinical and scientific conferences. The group is now working on an even more miniaturized binocular device. Further advances will be communicated.